A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study
John F. Carlquist(Intermountain Healthcare), Jeffrey L. Anderson(Intermountain Medical Center), David E. Moody(University of Utah), Wenfang B. Fang(University of Utah), Lynn R. Webster(Adherent Technologies (United States)), Jeffrey Rollo(Intermountain Healthcare), Stacey Knight(Intermountain Medical Center), John Huntinghouse(Intermountain Healthcare), Eric Johnson(Intermountain Healthcare)
Cited by 29
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article
|Circulation|2004|898
Multi-ethnic genome-wide association study for atrial fibrillation
|Nature Genetics|2018|824